The SEARCH Foundation, known for its transformative healthcare efforts in rural India, has announced a significant ...

KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...

Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted nipocalimab Breakthrough Therapy designation (BTD) for the treatment of adults living with moderate-to-severe ...

Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...

Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury: Toronto Wednesday, November 13, 2024, 1 ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...

Ophthalmology has emerged as a subject where artificial intelligence (AI) holds great promise. Major developments in artificial intelligence technology over the last five years have created new ...

Inter-ministerial committee calls for amendment in FSSAI Act on nutraceuticals: Gireesh Babu, New Delhi Wednesday, November 13, 2024, 08:00 Hrs [IST] An inter-ministerial committe ...

NABL announces joint technical training programme with MANTRA on medical textiles testing: Shardul Nautiyal, Mumbai Wednesday, November 13, 2024, 08:00 Hrs [IST] The National Accr ...

Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) jointly announce the start of a long-term collaboration as Boehringer becomes the first pharmaceutical company to join the ...

AstraZeneca to invest $3.5 billion in R&D and manufacturing in US: Cambridge, UK Wednesday, November 13, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science-led biopharmaceutical ...

Indian pharma stresses for enhanced fire safety measures and improved insurance coverage for employees: Nandita Vijayasimha, Bengaluru Wednesday, November 13, 2024, 08:00 Hrs [IST ...